Haemonetics (HAE)
(Delayed Data from NYSE)
$77.89 USD
-0.19 (-0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $77.82 -0.07 (-0.09%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$77.89 USD
-0.19 (-0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $77.82 -0.07 (-0.09%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth F Momentum F VGM
Zacks News
Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View
by Zacks Equity Research
Walgreens Boots Alliance, Inc. (WBA) reported adjusted earnings per share (EPS) of $1.10 in first-quarter fiscal 2017, up 6.8% from the year-ago quarter.
Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite
by Zacks Equity Research
Bruker Corporation (BRKR) recently announced the buyout of Hennigsdorf, Germany-based InVivo Biotech Services GmbH.
Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging
by Zacks Equity Research
Bruker Corporation (BRKR) recently announced the acquisition of Bremen, Germany-based software solutions developer, SCiLS GmbH.
ResMed Achieves Key Milestone in Sleep-Disordered Breathing
by Zacks Equity Research
After one billion nights of sleep data was downloaded using ResMed's remote patient monitoring platform AirView, the company reached a landmark in the field of sleep research and treatment of sleep apnea.
Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay
by Zacks Equity Research
Hologic, Inc. (HOLX) recently announced the receipt of the FDAs Premarket Approval (PMA) for its Aptima HIV-1 Quant assay.
Illumina Fettered With Losses: Can It Bounce Back in 2017?
by Zacks Equity Research
During majority of the past one year, Illumina (ILMN) lagged the Zacks classified broader Medical - Biomedical and Genetics industry.
Masimo to Launch Advanced Monitoring Technologies in India
by Zacks Equity Research
Masimo (MASI) announced that it will launch Advanced Monitoring Technologies in the Indian market.
OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3
by Zacks Equity Research
OPKO Health Inc. (OPK) announced failure in its data analysis of the Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults.
Abaxis (ABAX) Veterinary Prospects Bright: Should You Hold?
by Zacks Equity Research
On Jan 2, 2017, Abaxis Inc. (ABAX), a leading manufacturer of portable medical and veterinary blood analysis systems, was upgraded to a Zacks Rank #3 (Hold).
Is Baxter Poised to Counter Low Cyclophosphamide Sales?
by Zacks Equity Research
On Dec 30, we issued an updated research report on Deerfield, IL-based Baxter International Inc. (BAX), a global medical technology company and leading provider of renal and hospital products.
CryoLife (CRY) Now a Strong Buy on Solid Estimate Revisions
by Zacks Equity Research
On Dec 27, CryoLife Inc. (CRY) was upgraded to a Zacks Rank #1 (Strong Buy).
Alere (ALR) Appeals to Reinstate Medicare Billing Privilege
by Zacks Equity Research
Alere Inc. (ALR) announced that it has recently appealed at the Centers for Medicare & Medicaid Services for reinstatement of Medicare billing privilege.
NuVasive (NUVA) Wins MHLW Approval for XLIF Device Suite
by Zacks Equity Research
NuVasive (NUVA) recently announced the receipt of approval from MHLW, for instruments used in the eXtreme Lateral Interbody Fusion (XLIF) procedure.
LabCorp: Covance Drug Prospects Bright, Competition Rife
by Zacks Equity Research
On Dec 28, we issued an updated research report on Burlington, NC-based Laboratory Corporation of America Holdings (LH).
ResMed: SDB Business Faces Risks, Reimbursement a Drag
by Zacks Equity Research
On Dec 27, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD).
Nutrisystem Declares Multi-Brand Marketing Approach for '17
by Zacks Equity Research
Nutrisystem Inc. (NTRI) announced that it will focus on a multi-brand marketing approach with two new distinct programs.
Myriad Genetics' Unit Releases Favorable Data on Vectra DA
by Zacks Equity Research
Myriad Genetics, Inc.'s (MYGN) subsidiary, Crescendo Bioscience released favorable data on the use of Vectra DA to predict treatment response in patients with rheumatoid arthritis (RA).
Cardiovascular Systems (CSII): Q1 Solid, Net Losses Linger
by Zacks Equity Research
On Dec 27, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).
Haemonetics' Plasma Group Impresses, Blood Center a Drag
by Zacks Equity Research
On Dec 12, we issued an updated research report on Braintree, MA-based Haemonetics Corporation (HAE).
Haemonetics Introduces Upgraded NextGen DMS 4 Software
by Zacks Equity Research
Haemonetics Corporation (HAE) recently unveiled upgraded NextGen DMS (Donor Management System) to augment plasma collection center operations.